✦ LIBER ✦

PMH21 COST-EFFECTIVENESS-ANALYSIS OF RISPERIDONE LONG-ACTING INJECTION IN SCHIZOPHRENIA: 12 MONTH DATA FROM CZECH REPUBLIC

✍ Scribed by J Skoupá; V Cerna; T Doležl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH12 TREATMENT OUTCOMES OF RISPERIDONE

✍ I Tuma; J Pecenak; M Povey; A Lam; Z Zhao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Long acting injectable risperidone in th

✍ I. Tuma; M. Povey; A. Lam 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 44 KB

PMH35 COMPARATIVE EFFECTIVENESS OF LONG-

✍ C Carswell; A Wheeler; J Vanderpyl; E Robinson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PMH21 COST-EFFECTIVENESS OF OLANZAPINE L

✍ H Ascher-Svanum; NM Furiak; RW Klein; W Montgomery; LJ Smolen; AH Lawson; RR Con 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PMH28 Using Cost-Effectiveness Analysis

✍ A. Valencia-Mendoza; A. Hernández-Garduño 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB